Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Earnings Before Tax (EBT)
The ebt for Labcorp Holdings Inc. (LH) is $1.11 Billion with a year-over-year change of +15.42%. Earnings Before Tax (EBT), also called pre-tax income, represents a company's profit after all operating and non-operating expenses but before income tax expense.
LH EBT Chart
LH EBT
$1.11B+72.86% 20Y
Zoom
Current EBT
$1.11B
$1.11 Billion
Year-over-Year Change
+15.42%
vs. $959.50M prior year
Historical Data
30
Years of data available
Annual EBT History
| Year | EBT | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.11B | +$148.00M | +15.42% |
| 2024 | $959.50M | +$390.60M | +68.66% |
| 2023 | $568.90M | $-668.50M | -54.02% |
| 2022 | $1.24B | $-1.65B | -57.15% |
| 2021 | $2.89B | +$668.50M | +30.12% |
| 2020 | $2.22B | +$1.11B | +100.84% |
| 2019 | $1.10B | $-163.40M | -12.88% |
| 2018 | $1.27B | +$133.40M | +11.75% |
| 2017 | $1.13B | +$29.40M | +2.66% |
| 2016 | $1.11B | +$373.40M | +51.00% |
| 2015 | $732.10M | $-94.60M | -11.44% |
| 2014 | $826.70M | $-88.90M | -9.71% |
| 2013 | $915.60M | $-28.60M | -3.03% |
| 2012 | $944.20M | +$78.10M | +9.02% |
| 2011 | $866.10M | $-49.50M | -5.41% |
| 2010 | $915.60M | +$31.00M | +3.50% |
| 2009 | $884.60M | +$112.20M | +14.53% |
| 2008 | $772.40M | $-29.90M | -3.73% |
| 2007 | $802.30M | +$81.40M | +11.29% |
| 2006 | $720.90M | +$80.20M | +12.52% |
| 2005 | $640.70M | +$25.40M | +4.13% |
| 2004 | $615.30M | +$74.90M | +13.86% |
| 2003 | $540.40M | +$108.10M | +25.01% |
| 2002 | $432.30M | +$100.00M | +30.09% |
| 2001 | $332.30M | +$124.70M | +60.07% |
| 2000 | $207.60M | +$102.10M | +96.78% |
| 1999 | $105.50M | +$24.00M | +29.45% |
| 1998 | $81.50M | +$242.80M | +150.53% |
| 1997 | $-161.30M | +$27.00M | +14.34% |
| 1996 | $-188.30M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter